These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 38916406)

  • 1. NAT1 inhibits liver metastasis of colorectal cancer by regulating EMT and glycolysis.
    Gu W; Li C; Shen T; Tong L; Yuan W; Zheng X; Wang T; Wang S; Zhu B; Zhang C; Zhang C
    Aging (Albany NY); 2024 Jun; 16(12):10546-10562. PubMed ID: 38916406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NAT1 is a critical prognostic biomarker and inhibits proliferation of colorectal cancer through modulation of PI3K/Akt/mTOR.
    Cai J; Sun H; Chen L; Xie M; Zhuang J; Gao L; Wei XX
    Future Oncol; 2021 Jul; 17(19):2489-2498. PubMed ID: 33906370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ARHGAP9 inhibits colorectal cancer cell proliferation, invasion and EMT via targeting PI3K/AKT/mTOR signaling pathway.
    Sun J; Zhao X; Jiang H; Yang T; Li D; Yang X; Jia A; Ma Y; Qian Z
    Tissue Cell; 2022 Aug; 77():101817. PubMed ID: 35679685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitor of DNA binding 2 knockdown inhibits the growth and liver metastasis of colorectal cancer.
    Liu F; Chen S; Yu Y; Huang C; Chen H; Wang L; Zhang W; Wu J; Ye Y
    Gene; 2022 Apr; 819():146240. PubMed ID: 35114275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiR-206 inhibits HGF-induced epithelial-mesenchymal transition and angiogenesis in non-small cell lung cancer via c-Met /PI3k/Akt/mTOR pathway.
    Chen QY; Jiao DM; Wu YQ; Chen J; Wang J; Tang XL; Mou H; Hu HZ; Song J; Yan J; Wu LJ; Chen J; Wang Z
    Oncotarget; 2016 Apr; 7(14):18247-61. PubMed ID: 26919096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IMPDH2 promotes colorectal cancer progression through activation of the PI3K/AKT/mTOR and PI3K/AKT/FOXO1 signaling pathways.
    Duan S; Huang W; Liu X; Liu X; Chen N; Xu Q; Hu Y; Song W; Zhou J
    J Exp Clin Cancer Res; 2018 Dec; 37(1):304. PubMed ID: 30518405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoxia-induced Nur77 activates PI3K/Akt signaling
    Shi Z; To SKY; Zhang S; Deng S; Artemenko M; Zhang M; Tang J; Zeng JZ; Wong AST
    Theranostics; 2021; 11(7):3376-3391. PubMed ID: 33537093
    [No Abstract]   [Full Text] [Related]  

  • 8. Highly-expressed P2X7 receptor promotes growth and metastasis of human HOS/MNNG osteosarcoma cells via PI3K/Akt/GSK3β/β-catenin and mTOR/HIF1α/VEGF signaling.
    Zhang Y; Cheng H; Li W; Wu H; Yang Y
    Int J Cancer; 2019 Aug; 145(4):1068-1082. PubMed ID: 30761524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Daidzin targets epithelial-to-mesenchymal transition process by attenuating manganese superoxide dismutase expression and PI3K/Akt/mTOR activation in tumor cells.
    Yang MH; Jung SH; Um JY; Kumar AP; Sethi G; Ahn KS
    Life Sci; 2022 Apr; 295():120395. PubMed ID: 35181309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chanling Gao suppresses colorectal cancer via PI3K/Akt/mTOR pathway modulation and enhances quality of survival.
    Chen G; Tian TT; Wang FQ; Pan CS; Sun K; Wang XY; Yang B; Yang Z; Tang DX; Han JY
    Environ Toxicol; 2024 Mar; 39(3):1107-1118. PubMed ID: 37823609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AIM2 inhibits colorectal cancer cell proliferation and migration through suppression of Gli1.
    Xu M; Wang J; Li H; Zhang Z; Cheng Z
    Aging (Albany NY); 2020 Dec; 13(1):1017-1031. PubMed ID: 33291082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FAT4 regulates the EMT and autophagy in colorectal cancer cells in part via the PI3K-AKT signaling axis.
    Wei R; Xiao Y; Song Y; Yuan H; Luo J; Xu W
    J Exp Clin Cancer Res; 2019 Mar; 38(1):112. PubMed ID: 30832706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MYSM1 inhibits human colorectal cancer tumorigenesis by activating miR-200 family members/CDH1 and blocking PI3K/AKT signaling.
    Chen X; Wang W; Li Y; Huo Y; Zhang H; Feng F; Xi W; Zhang T; Gao J; Yang F; Chen S; Yang A; Wang T
    J Exp Clin Cancer Res; 2021 Oct; 40(1):341. PubMed ID: 34706761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of AKT signaling promotes epithelial-mesenchymal transition and tumor growth in colorectal cancer cells.
    Suman S; Kurisetty V; Das TP; Vadodkar A; Ramos G; Lakshmanaswamy R; Damodaran C
    Mol Carcinog; 2014 Feb; 53 Suppl 1():E151-60. PubMed ID: 24000138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exclusive inhibition of PI3K/Akt/mTOR signaling is not sufficient to prevent PDGF-mediated effects on glycolysis and proliferation in colorectal cancer.
    Moench R; Grimmig T; Kannen V; Tripathi S; Faber M; Moll EM; Chandraker A; Lissner R; Germer CT; Waaga-Gasser AM; Gasser M
    Oncotarget; 2016 Oct; 7(42):68749-68767. PubMed ID: 27626684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor suppressive effect of scavenger receptor class A member 5 overexpression in colorectal cancer by regulating PI3K/AKT/mTOR pathway.
    Li Y; Peng F; Tan X; Wang J; Xu Y
    Genes Genomics; 2021 Oct; 43(10):1189-1198. PubMed ID: 34417976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [LncRNA SNHG11 promotes malignant progression of colorectal cancer cells through the PI3K/Akt/mTOR signaling pathway].
    Tao SN; Liu XC; Wang YY; Yang H
    Zhonghua Yi Xue Za Zhi; 2024 Mar; 104(10):758-765. PubMed ID: 38462356
    [No Abstract]   [Full Text] [Related]  

  • 18. Silencing of FOXO6 inhibits the proliferation, invasion, and glycolysis in colorectal cancer cells.
    Li Q; Tang H; Hu F; Qin C
    J Cell Biochem; 2019 Mar; 120(3):3853-3860. PubMed ID: 30321450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DCLK1 promotes epithelial-mesenchymal transition via the PI3K/Akt/NF-κB pathway in colorectal cancer.
    Liu W; Wang S; Sun Q; Yang Z; Liu M; Tang H
    Int J Cancer; 2018 May; 142(10):2068-2079. PubMed ID: 29277893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Echinacoside inhibits colorectal cancer metastasis via modulating the gut microbiota and suppressing the PI3K/AKT signaling pathway.
    Wei J; Zheng Z; Hou X; Jia F; Yuan Y; Yuan F; He F; Hu L; Zhao L
    J Ethnopharmacol; 2024 Jan; 318(Pt A):116866. PubMed ID: 37429503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.